Validation and Comparison of two Risk stratification Models in st segment elevation Myocardial Infarction
pp. 119-124
DOI:
https://doi.org/10.7775/rac.es.v87.i2.13339Keywords:
Myocardial infarction – ST elevation myocardial infarction - Acute coronary syndrome – PrognosisAbstract
Background: Risk scores are recommended to stratify and predict mortality in ST-segment elevation acute myocardial infarction (STEMI). The ProACS and Simple Risk Index (SRI) models are simple scores that have demonstrated adequate predictive capacity of in-hospital mortality in other countries.
Objective: The aim of this study was to validate and compare the ProACS and SRI scores as predictors of in-hospital mortality in patients with STEMI.
Methods: This was a retrospective analysis of a cohort composed of consecutive patients from the CONAREC XVII registry hospitalized with STEMI diagnosis. The predictive value for in-hospital mortality was estimated and validity was assessed by discrimination and calibration.
Results: The study analyzed 694 patients. In-hospital mortality was 8.78%. The median ProACS score was 4 (IQR 25-75, 2.5-5) in patients who presented the event, and 2 (IQR 25-75 1-3) in those without the event (p <0.001) and the median SRI score was 41.3 (IQR 25-75, 29.8-62.5) and 20.8 (IQR 25-75 15.4-30) in those who died and those who did not, respectively (p <0.001). The SRI score showed excellent discrimination (AUC 0.83, 95% CI 0.78-0.88, p=0.001) and the ProACS score evidenced good discrimination (AUC 0.78, 95% CI 0.71-0.86, p = 0.001) for the outcome. The HL test applied to the ProACS score presented χ2=8.6 (p=0.3), and the SRI score χ2=5.4 (p=0.7).
Conclusions: The ProACS and SRI risk scores for the prediction of in-hospital mortality were adequately validated in patients with STEMI in Argentina. This suggests their suitability for clinical use in this population.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.








